800

EFFICACY AND SAFETY OF SUBCUTANEOUS GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS THROUGH WEEK 24 FROM THE PHASE 3 ASTRO STUDY

Date
May 5, 2025
Explore related products in the following collection: